Tokyo, July 11, 2019: Eisai Co., Ltd. announced today that a total of 13 presentations containing two oral presentations including…
Thirteen presentations to be given including on Phase II study results of BAN2401 and elenbecestat Tokyo, July 23, 2018: Eisai…